Influence of Pulmonary Hypertension on Patients With Idiopathic Pulmonary Fibrosis Awaiting Lung Transplantation Don Hayes, MD, MS, Sylvester M. Black,

Slides:

Advertisements

Similar presentations

Survival After Single Versus Bilateral Lung Transplantation for High-Risk Patients With Pulmonary Fibrosis Eric S. Weiss, MD, MPH, Jeremiah G. Allen,

Advertisements

Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.

Survival Benefit of Aortic Valve Replacement in Patients With Severe Aortic Stenosis With Low Ejection Fraction And Low Gradient With Normal Ejection.

Elizabeth A. David, MD, David T

Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,

Repeated Target Vessel Revascularization After Coronary Artery Bypass for In-Stent Restenosis Jung-Hwan Kim, MD, Seung Hyun Lee, MD, PhD, Hyun-Chel Joo,

Mauer Biscotti, MD, Whitney D

Benny Weksler, MD, Jennifer L. Sullivan, MD

Niv Ad, MD, Linda Henry, PhD, RN, Deborah J. Shuman, BS, Sari D

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Chun Chieh Lin, PhD, MBA, Matthew P

Jeevan Nagendran, MD, Colleen M. Norris, PhD, Michelle M

Joshua E. Rosen, BASc, Hari B

Mortality Risk and Pulmonary Function in Adults With Cystic Fibrosis at Time of Wait Listing for Lung Transplantation Don Hayes, MD, MS, Stephen Kirkby,

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery Farkas B. Vánky, MD, PhD, Erik.

Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis Takekazu Iwata, MD, PhD, Shigetoshi Yoshida,

ABO-Identical Blood Group Matching Has No Survival Benefit for AB Heart Transplant Recipients Henrik Bergenfeldt, MD, Peter Höglund, MD, PhD, Bodil Andersson,

Comparing Long-Term Survival Between Patients Undergoing Off-Pump and On-Pump Coronary Artery Bypass Graft Operations Giovanni Filardo, PhD, MPH, Paul.

Robert E. Merritt, MD, Richard I. Whyte, MD, Nicole T

The Impact of Peripheral Vascular Disease on Long-Term Survival After Coronary Artery Bypass Graft Surgery Danny Chu, MD, Faisal G. Bakaeen, MD, Xing.

B. Zane Atkins, MD, Rebecca P. Petersen, MD, MS, Mani A

Lung transplantation for primary and secondary pulmonary hypertension

Less Is More in Post Pediatric Heart Transplant Care

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Operative Results and Outcomes in Children With Shone's Anomaly

Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.

Aortic Valve Replacement Improves Survival in Severe Aortic Stenosis Associated With Severe Pulmonary Hypertension Ramdas G. Pai, MD, Padmini Varadarajan,

The Annals of Thoracic Surgery

Venous Thromboembolic Complications of Lung Transplantation: A Contemporary Single-Institution Review Charles F. Evans, MD, Aldo T. Iacono, MD, Pablo.

Varun Puri, MD, Andrew Tran, MS, Jennifer M. Bell, BS, Traves D

Pulmonary Resection in the Treatment of Multidrug-Resistant Tuberculosis: A Retrospective Study of 56 Cases Haifeng Wang, MM, Hongsheng Lin, MM, Gening.

Reversible Pulmonary Hypertension in Heart Transplant Candidates: To Transplant or Not to Transplant Stefan Klotz, MD, Frauke Wenzelburger, MD, Joerg.

Samuel P. Morreau, David A. Haydock, MBChB, FRACS

Lung Cancer Surgery in Patients With Liver Cirrhosis

Total Arterial Revascularization: A Superior Strategy for Diabetic Patients Who Require Coronary Surgery James Tatoulis, MD, FRACS, Rochelle Wynne, PhD,

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Impact of Lepidic Component Occupancy on Effects of Adjuvant Chemotherapy for Lung Adenocarcinoma Shinsuke Sasada, MD, PhD, Yoshihiro Miyata, MD, PhD,

Impact of Preoperative Symptoms on Postoperative Survival in Severe Aortic Stenosis: Implications for the Timing of Surgery Sophie Piérard, MD, Christophe.

Quality Measures in Clinical Stage I Non-Small Cell Lung Cancer: Improved Performance Is Associated With Improved Survival Pamela Samson, MD, MPHS, Traves.

Age-Dependent Gender Disparities in Post Lung Transplant Survival Among Patients With Idiopathic Pulmonary Fibrosis Shahid I. Sheikh, MD, Don Hayes,

Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E

Impact of Blood Product Transfusion on Short and Long-Term Survival After Cardiac Surgery: More Evidence Balu Bhaskar, MD, FCICM, Joel Dulhunty, PhD,

Survival After Surgery for Pathologic Stage IA Non-Small Cell Lung Cancer Associated With Idiopathic Pulmonary Fibrosis Yuichi Saito, MD, Yasuyuki Kawai,

Felix G. Fernandez, MD, Onkar Khullar, MD, Seth D

Acute Kidney Injury Increases Mortality After Lung Transplantation

Kathryn E. Engelhardt, MD, Malcolm M. DeCamp, MD, Anthony D

Eric S. Weiss, MD, MPH, Jeremiah G. Allen, MD, Christian A

Adriaan W. Schneider, MD, Nico A. Blom, MD, PhD, Eline F

Posttransplant Outcomes Among Septuagenarians Bridged to Transplantation With Continuous-Flow Left Ventricular Assist Devices Shinichi Fukuhara, MD,

Editorial Board, January 2010

William M. Whited, MD, Paul Henley, BS, Erin M

Asvin M. Ganapathi, MD, Paul J. Speicher, MD, Anthony W

Pretransplant Panel Reactive Antibodies in Human Lung Transplantation: An Analysis of Over 10,000 Patients Ashish S. Shah, MD, Lois Nwakanma, MD, Christopher.

A. Thomas Pezzella, MD, Sari D

Single Versus Double Lung Retransplantation Does Not Affect Survival Based on Previous Transplant Type Erin M. Schumer, MD, MPH, Jonathan D. Rice, MD,

Adhering to Quality Measures in Esophagectomy Is Associated With Improved Survival in All Stages of Esophageal Cancer Pamela Samson, MD, MPHS, Varun.

Survival After Isolated Coronary Artery Bypass Grafting in Patients With Severe Left Ventricular Dysfunction Waleed A. Ahmed, MD, Phillip J. Tully, BHSc(Hons),

Trends in Patient Characteristics and Outcomes of Coronary Artery Bypass Grafting in the 2000 to 2012 Medicare Population Christian McNeely, MD, Stephen.

Effects of Delayed Surgical Resection on Short-Term and Long-Term Outcomes in Clinical Stage I Non-Small Cell Lung Cancer Pamela Samson, MD, Aalok Patel,

Immediate and Long-Term Survival After Surgery for Lung Cancer in Heart Transplant Recipients Patrick Bagan, MD, Jalal Assouad, MD, Pascal Berna, MD,

Do Patients With Complete Transposition of the Great Arteries and Severe Pulmonary Hypertension Benefit From an Arterial Switch Operation? Hongguang.

Steve K. Singh, MD, Gilbert H. L. Tang, MD, Manjula D

Bilateral Internal Thoracic Artery Grafts in Hemodialysis: A Single-Center Propensity Score Analysis Yoshinori Nakahara, MD, Shigehiko Yoshida, MD, Takeyuki.

Patient-Prosthesis Mismatch After Mitral Valve Replacement: A Propensity Score Analysis Ho Young Hwang, MD, PhD, Yong Han Kim, MD, Kyung-Hwan Kim, MD,

Clinical Outcome After Pulmonary Resection for Lung Cancer Patients on Hemodialysis Toshiro Obuchi, MD, Wakako Hamanaka, MD, Yasuhiro Yoshida, MD, Jun.

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Utilization and Outcomes of Unprotected Left Main Coronary Artery Stenting and Coronary Artery Bypass Graft Surgery Chuntao Wu, MD, PhD, Edward L. Hannan,

Lung Transplantation for Idiopathic Pulmonary Fibrosis

Kim I. de la Cruz, MD, Faisal G

Presentation transcript:

Influence of Pulmonary Hypertension on Patients With Idiopathic Pulmonary Fibrosis Awaiting Lung Transplantation Don Hayes, MD, MS, Sylvester M. Black, MD, PhD, Joseph D. Tobias, MD, Stephen Kirkby, MD, Heidi M. Mansour, PhD, Bryan A. Whitson, MD, PhD The Annals of Thoracic Surgery Volume 101, Issue 1, Pages 246-252 (January 2016) DOI: 10.1016/j.athoracsur.2015.06.024 Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Patient inclusion and exclusion criteria for patients with idiopathic pulmonary fibrosis (IPF) and subsequent univariate analysis, Kaplan-Meier survival curve, multivariate Cox analysis, and propensity score matching. (PH = pulmonary hypertension.) The Annals of Thoracic Surgery 2016 101, 246-252DOI: (10.1016/j.athoracsur.2015.06.024) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Kaplan-Meier survival functions comparing pulmonary hypertension (blue line) and no pulmonary hypertension (red line) in patients with idiopathic pulmonary fibrosis using mean pulmonary artery pressure 25 mm Hg or greater as the threshold (n = 6,126; log rank test χ2 [df = 1] 40.44, p < 0.001). The Annals of Thoracic Surgery 2016 101, 246-252DOI: (10.1016/j.athoracsur.2015.06.024) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Kaplan-Meier survival functions comparing pulmonary hypertension (blue line) and no pulmonary hypertension (red line) in patients with idiopathic pulmonary fibrosis using mean pulmonary artery pressure 35 mm Hg or greater as the threshold (n = 6,126; log rank test χ2 [df = 1] 60.62, p < 0.001). The Annals of Thoracic Surgery 2016 101, 246-252DOI: (10.1016/j.athoracsur.2015.06.024) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions